Related Experiment Video
Updated: Jun 5, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Dithiothreitol causes HIV-1 integrase dimer dissociation while agents interacting with the integrase dimer interface
Manuel Tsiang1, Gregg S Jones, Magdeleine Hung
1Gilead Sciences, 333 Lakeside Drive, Foster City, California 94404, United States. MTsiang@gilead.com
Insights
A new assay detects HIV-1 integrase (IN) dimers. Surprisingly, dithiothreitol (DTT) weakens IN dimerization, while LEDGF peptides and small molecules stabilize IN dimers, impacting HIV-1 replication.
Area of Science:
- Biochemistry
- Virology
- Molecular Biology
Background:
- HIV-1 integrase (IN) is a critical enzyme for viral replication.
- Understanding IN dimerization is essential for developing antiviral strategies.
- The interaction between IN and its cofactor LEDGF is a key target for drug development.
Purpose of the Study:
- To develop a homogeneous time-resolved FRET-based assay for detecting HIV-1 IN dimers.
- To investigate the effect of dithiothreitol (DTT) on IN dimerization.
- To evaluate the impact of LEDGF-derived peptides and small molecules on IN dimerization.
Main Methods:
- Homogeneous time-resolved fluorescence resonance energy transfer (FRET) assay.
- Utilized epitope-tagged IN monomers coupled to distinct fluorophores.
- Studied IN mutants and peptides derived from LEDGF.
- Mathematical modeling of binding kinetics.
Main Results:
- Dithiothreitol (DTT), an essential reducing agent, unexpectedly weakened IN monomer interaction.
- Threitol, lacking thiol groups, did not affect IN dimer formation, indicating DTT's thiol groups are responsible.
- LEDGF-derived peptides and a small molecule inhibitor of LEDGF binding promoted IN dimerization and blocked subunit exchange.
- Cysteine residues in IN were found to be dispensable for DTT's dimer dissociation effect.
Conclusions:
- A novel FRET assay effectively detects HIV-1 IN dimerization.
- DTT's thiol groups destabilize IN dimers, contrary to its role in enzymatic activity.
- Peptide and small molecule inhibitors targeting the IN-LEDGF interaction stabilize IN dimers, suggesting a new therapeutic avenue.
Abstract:
We have developed a homogeneous time-resolved fluorescence resonance energy transfer (FRET)-based assay that detects the formation of HIV-1 integrase (IN) dimers. The assay utilizes IN monomers that express two different epitope tags that are recognized by their respective antibodies, coupled to distinct fluorophores. Surprisingly, we found that dithiothreitol (DTT), a reducing agent essential for in vitro enzymatic activity of IN, weakened the interaction between IN monomers. This effect of DTT on IN is dependent on its thiol groups, since the related chemical threitol, which contains hydroxyls in place of thiols, had no effect on IN dimer formation. By studying mutants of IN, we determined that cysteines in IN appear to be dispensable for the dimer dissociation effect of DTT. Peptides derived from the IN binding domain (IBD) of lens epithelium derived growth factor/transcriptional coactivator p75 (LEDGF), a cellular cofactor that interacts with the IN dimer interface, were tested in this IN dimerization assay. These peptides, which compete with LEDGF for binding to IN, displayed an intriguing equilibrium binding dose-response curve characterized by a plateau rising to a peak, then descending to a second plateau. Mathematical modeling of this binding system revealed that these LEDGF-derived peptides promote IN dimerization and block subunit exchange between IN dimers. This dose-response behavior was also observed with a small molecule that interacts with the IN dimer interface and inhibits LEDGF binding to IN. In conclusion, this novel IN dimerization assay revealed that peptide and small molecule inhibitors of the IN-LEDGF interaction also stabilize IN dimers and promote their formation.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Intracellular Signaling Affects Focal Adhesions
Some...
Protein-protein Interfaces
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Preparation and Reactions of Thiols

